Comparative effects of omeprazole, amoxycillin plus metronidazole versus omeprazole, clarithromycin plus metronidazole on the oral, gastric and intestinal microflora in Helicobacter pylori-infected patients

Journal of Antimicrobial Chemotherapy

Volumn 44, Issue 5, 1999, Pages 629-640

  Adamsson, Inger ^a   Nord, Carl Erik ^a   Lundquist, Per ^a   Sjöstedt, Svante ^a   Edlund, Charlotta ^a,b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b SÖDERTÖRN UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; METRONIDAZOLE; OMEPRAZOLE;

ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL OVERGROWTH; BACTEROIDES; CLINICAL ARTICLE; ENTEROBACTERIACEAE; FECES ANALYSIS; FEMALE; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; INTESTINE FLORA; MALE; MINIMUM INHIBITORY CONCENTRATION; MOUTH FLORA; ORAL DRUG ADMINISTRATION; SALIVA ANALYSIS; STOMACH BIOPSY; STREPTOCOCCUS; TIME; TREATMENT OUTCOME; YEAST;

ADULT; AGED; AMOXICILLIN; ANTI-BACTERIAL AGENTS; ANTI-ULCER AGENTS; CLARITHROMYCIN; DRUG THERAPY, COMBINATION; DYSPEPSIA; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INTESTINES; MALE; METRONIDAZOLE; MIDDLE AGED; MOUTH; OMEPRAZOLE; PENICILLINS; STOMACH;

EID: 0032731580     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/44.5.629     Document Type: Article

References (28)

1. Bell, G. D. & Powell, K. U. (1993). Eradication of Helicobacter pylori and its effect in peptic ulcer disease. Scandinavian Journal of Gastroenterology 28, Suppl. 196, 7-11.
2. Labenz, J., Gyenes E., Rühl G. H. & Börsch, G. (1993). Omeprazole plus amoxycillin: efficacy of various treatment regimens to eradicate Helicobacter pylori. American Journal of Gastroenterology 88, 491-5.
3. Lind, T., van Zanten, S. V., Unge, P., Spiller, R. C., Bayerdorffer, E., O'Morain, C. et al. (1996). Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: MACH I Study. Helicobacter 1, 138-44.
4. Hunt, R. H. (1997). Peptic ulcer disease: defining the treatment strategies in the era of Helicobacter pylori. American Journal of Gastroenterology 92, Suppl. 4, 36S-40S.
5. The European Helicobacter pylori Study Group. (1997). Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report. Gut 41, 8-13.
6. Edlund, C. & Nord, C. E. (1993). Ecological impact of antimicrobial agents on human intestinal microflora. Alpe Adria Microbiology Journal 2, 137-64.
7. Stark, C. A., Adamsson, I., Edlund, C., Sjöstedt, S., Seensalu, R., Wikström, B. et al. (1996). Effects of omeprazole and amoxycillin on the human oral and gastrointestinal microflora in patients with Helicobacter pylori infection. Journal of Antimicrobial Chemotherapy 38, 927-39.
8. Möller, Å. J. R. (1966). Microbiological examination of root canals and periapical tissues of human teeth. Scandinavian Dental Journal 74, 5-6.
9. 13-urea breath test. Scandinavian Journal of Clinical and Laboratory Investigation 57, 689-94.
10. Heimdahl, A. & Nord, C. E. (1979). Effect of phenoxymethylpenicillin and clindamycin on the oral, throat and faecal microflora of man. Scandinavian Journal of Infectious Diseases 11, 233-42.
11. Adamsson, I., Seensalu, R., Sjöstedt, S., Wikström, B. & Nord, C. E. (1998). The value of different detection methods of Helicobacter pylori treatment. Journal of Clinical Gastroenterology 27, 138-42.
12. Nord, C. E. & Edlund, C. (1990). Impact of antimicrobial agents on human intestinal microflora. Journal of Chemotherapy 2, 218-37.
13. National Committee for Clinical Laboratory Standards. (1997). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically - Fourth Edition: Approved Standard M7-A4. NCCLS, Villanova, PA.
14. National Committee for Clinical Laboratory Standards. (1997). Methods for Antimicrobial Susceptibility Testing of Anaerobic Bacteria - Fourth Edition: Approved Standard M11-A4. Vol. 17, No. 2. NCCLS, Villanova, PA.
15. Blaser, M. J. (1998). Helicobacter pylori and gastric diseases. British Medical Journal 316, 1507-10.
16. NIH Consensus Development Panel on Helicobacter pylori in Peptic Ulcer Disease. (1994). Helicobacter pylori in peptic ulcer disease. Journal of the American Medical Association 272, 65-9.
17. Hunt, R. H. (1993). Hp and pH: implications for the eradication of Helicobacter pylori. Scandinavian Journal of Gastroenterology 28, Suppl. 196, 12-6.
18. Cederbrant, G., Kahlmeter, G., Schalen, C. & Kamme, C. (1994). Additive effect of clarithromycin combined with 14-hydroxy clarithromycin, erythromycin, amoxycillin, metronidazole, or omeprazole against Helicobacter pylori. Journal of Antimicrobial Chemotherapy 34, 1025-9.
19. Sjöstedt, S., Sagar, M., Lindberg, G., Wikström, B., Nord, C. E. & Seensalu, R. (1998). Prolonged and profound acid inhibition is crucial in Helicobacter pylori treatment with a proton pump inhibitor combined with amoxycillin. Scandinavian Journal of Gastroenterology 33, 39-43.
20. Peterson, W. L. (1997). The role of antisecretory drugs in the treatment of Helicobacter pylori infection. Alimentary Pharmacology and Therapeutics 11, Suppl. 1, 21-5.
21. Adamsson, I., Edlund, C., Seensalu, R., Sjöstedt, S. & Nord, C. E. (1998). The normal gastric microflora and Helicobacter pylori; before, during and after treatment with omeprazole and amoxycillin. Clinical Microbiology and Infection 4, 308-15.
22. Edlund, C., Stark, C. & Nord, C. E. (1994).The relationship between an increase in β-lactamase activity after oral administration of three new cephalosporins and protection against intestinal ecological disturbances. Journal Antimicrobial Chemotherapy 34, 127-38.
23. van der Waaij, D. (1989). The ecology of the human intestine and its consequences for overgrowth by pathogens such as Clostridium difficile. Annual Review of Microbiology 43, 69-87.
24. Brismar, B., Edlund, C. & Nord, C. E. (1991). Comparative effects of clarithromycin and erythromycin on the normal intestinal microflora. Scandinavian Journal of Infectious Diseases 23, 635-42.
25. Kager, L., Ljungdahl, I., Malmborg, A. S. & Nord C. E. (1981). Effect of tinidazole prophylaxis on the normal microflora in patients undergoing colorectal sugery. Scandinavian Journal of Infectious Diseases 26, Suppl., 84-91.
26. Bergan, T., Solhaug, J. H., Soreide, O. & Leinebo, O. (1985). Comparative pharmacokinetics of metronidazole and tinidazole and their tissue penetration. Scandinavian Journal of Gastroenterology 20, 945-50.
27. Finegold, S. (1995). Anaerobic infections in humans: an overview. Anaerobe 1, 3-9.
28. Goodwin, C. S. & Armstrong, J. A. (1990). Microbiological aspects of Helicobacter pylori (Campylobacter pylon). European Journal of Clinical Microbiology and Infectious Diseases 9, 1-13.